However, the effects do not last long, and it may lead to stress reactions, requiring multiple injections in a short time, which is time-consuming and expensive
Hims & Hers CEO Andrew Dudum told investors and analysts on the call that, within six weeks of introducing direct access to Novo Nordisk's GLP-1 products on its platform, the company has fulfilled more than 125,000 shipments for Wegovy products
Building on these findings, clinical trials are now investigating these therapeutic applications more systematically, including studies examining incretin agonists for both alcohol consumption and alcohol-related disorders (ClinicalTrials.gov identifiers: NCT06546384, NCT06409130, NCT07046819, NCT05891587, NCT05895643, NCT06015893, NCT05892432, NCT06939088, NCT06727331, and NCT06994338)
Weekly GLP-1 injections: Zepbound both vial and prefilled pen (tirzepatide)